thalidomide has been researched along with Leukoencephalopathy Syndrome, Posterior in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, S | 1 |
| Cheung, CS | 1 |
| Lee, DH | 1 |
| Howson-Jan, K | 1 |
| Xenocostas, A | 1 |
| Ohya, E | 1 |
| Mizutani, M | 1 |
| Sekine, T | 1 |
2 other studies available for thalidomide and Leukoencephalopathy Syndrome, Posterior
| Article | Year |
|---|---|
Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide.
Topics: Female; Humans; Middle Aged; Multiple Myeloma; Posterior Leukoencephalopathy Syndrome; Thalidomide | 2012 |
[Case report: Reversible posterior leukoencephalopathy associated with the treatment of multiple myeloma: a case report].
Topics: Antineoplastic Agents; Female; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Posterior Leukoe | 2012 |